Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H19F2N3O3 |
| Molecular Weight | 399.3907 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOCN1C2=CC(F)=CC=C2N3CCC(=O)C(C(=O)NC4=C(F)C=CC=C4)=C13
InChI
InChIKey=VQOQDABVGWLROX-UHFFFAOYSA-N
InChI=1S/C21H19F2N3O3/c1-2-29-12-26-17-11-13(22)7-8-16(17)25-10-9-18(27)19(21(25)26)20(28)24-15-6-4-3-5-14(15)23/h3-8,11H,2,9-10,12H2,1H3,(H,24,28)
| Molecular Formula | C21H19F2N3O3 |
| Molecular Weight | 399.3907 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:49:57 GMT 2023
by
admin
on
Sat Dec 16 11:49:57 GMT 2023
|
| Record UNII |
NNJ1LL72JS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
NNJ1LL72JS
Created by
admin on Sat Dec 16 11:49:57 GMT 2023 , Edited by admin on Sat Dec 16 11:49:57 GMT 2023
|
PRIMARY | |||
|
205701-85-5
Created by
admin on Sat Dec 16 11:49:57 GMT 2023 , Edited by admin on Sat Dec 16 11:49:57 GMT 2023
|
PRIMARY | |||
|
DTXSID90431349
Created by
admin on Sat Dec 16 11:49:57 GMT 2023 , Edited by admin on Sat Dec 16 11:49:57 GMT 2023
|
PRIMARY | |||
|
9822240
Created by
admin on Sat Dec 16 11:49:57 GMT 2023 , Edited by admin on Sat Dec 16 11:49:57 GMT 2023
|
PRIMARY | |||
|
RWJ-51204
Created by
admin on Sat Dec 16 11:49:57 GMT 2023 , Edited by admin on Sat Dec 16 11:49:57 GMT 2023
|
PRIMARY | RWJ-51204 is an anxiolytic drug used in scientific research. It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic. RWJ-51204 is a nonselective partial agonist at GABAA receptors. It produces primarily anxiolytic effects at low doses, with sedative, ataxia and muscle relaxant effects only appearing at some 20x the effective anxiolytic dose.(2) It was discovered by researchers at the pharmaceutical company Johnson & Johnson, but its development has been discontinued. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
